Bismuth quadruple regimen containing furazolidone and tetracycline as a promising strategy for Helicobacter pylori initial and rescue therapy: A prospective cohort study

被引:0
|
作者
Peng, Jianxiang [1 ]
Xie, Jinliang [1 ]
Wu, Shuang [1 ]
Liu, Dingwei [1 ]
Yang, Kaijie [1 ]
Huang, Deqiang [1 ]
Xie, Yong [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
关键词
eradication; furazolidone; H; pylori; tetracycline;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
0017
引用
收藏
页码:17 / 17
页数:1
相关论文
共 50 条
  • [21] Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen
    Ming-Tsung Hsieh
    Wei-Lun Chang
    Chung-Tai Wu
    Hsiao-Bai Yang
    Hsin-Yu Kuo
    Meng-Ying Lin
    Hsiu-Chi Cheng
    Yu-Chin Tsai
    Bor-Shyang Sheu
    [J]. European Journal of Clinical Pharmacology, 2020, 76 : 1581 - 1589
  • [22] Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
    Veysari, Arash Kazemi
    Rahimi, Ali
    Maleki, Iradj
    Fakheri, Hafez Tirgar
    Taghvaei, Tarang
    Hosseini, Vahid
    Toosi, Seyed Mohammad Valizadeh
    Masoumi, Danial
    Bari, Zohreh
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (04) : 676 - 680
  • [23] Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication
    Lee, Jung Won
    Kim, Nayoung
    Nam, Ryoung Hee
    Lee, Sun Min
    Soo In, Choi
    Kim, Jung Mogg
    Lee, Dong Ho
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (04) : 666 - 672
  • [24] Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized study
    Li, Huan
    Xia, Xiu-Juan
    Zhang, Lin-Fang
    Chi, Jing-Shu
    Liu, Peng
    Wu, Hao
    Xie, Xiao-Ran
    Tian, De-Lin
    Kun, Kai-Xiao
    Gong, Ren-Jie
    Liu, Xiao-Ming
    Xu, Can-Xia
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (02) : 194 - 200
  • [25] Bismuth containing quadruple therapy for second line Helicobacter pylori eradication
    Lee, M.
    Lee, B.
    Kim, G.
    Park, E.
    Jeon, H.
    Song, G.
    [J]. HELICOBACTER, 2017, 22
  • [26] Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
    Bang, Chang Seok
    Lim, Hyun
    Jeong, Hae Min
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    [J]. GUT MICROBES, 2020, 11 (05) : 1314 - 1323
  • [27] Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection
    Saracino, Ilaria M.
    Pavoni, Matteo
    Zullo, Angelo
    Fiorini, Giulia
    Saccomanno, Laura
    Lazzarotto, Tiziana
    Antonelli, Guido
    Cavallo, Rossana
    Borghi, Claudio
    Vaira, Dino
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 81 : 50 - 53
  • [28] A modified Bismuth-Containing Quadruple Therapy Including a Short Course of Furazolidone for Helicobacter pylori Eradication After Sequential Therapy Failure
    Fakheri, Hafez
    Bari, Zohreh
    Sardarian, Hossein
    [J]. HELICOBACTER, 2012, 17 (04) : 264 - 268
  • [29] Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains
    Muller, Nelly
    Amiot, Aurelien
    Le Thuaut, Aurelie
    Bastuji-Garin, Sylvie
    Deforges, Lionel
    Delchier, Jean-Charles
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (04) : 517 - 524
  • [30] Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole
    Isakov, V
    Domareva, I
    Koudryavtseva, L
    Maev, I
    Ganskaya, Z
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (07) : 1277 - 1282